{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T11:51:15Z","timestamp":1772711475770,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd012708","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T00:00:00Z","timestamp":1533513600000}}],"reference-count":104,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012708.pub2","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T10:10:50Z","timestamp":1533636650000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Mirtazapine for fibromyalgia in adults"],"prefix":"10.1002","author":[{"given":"Patrick","family":"Welsch","sequence":"additional","affiliation":[{"name":"Health Care Center for Pain Medicine and Mental Health; Saarbr\u00fccken Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathrin","family":"Bernardy","sequence":"additional","affiliation":[{"name":"Department of Pain Medicine; BG University Hospital Bergmannsheil GmbH, Ruhr University Bochum; Bochum Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheena","family":"Derry","sequence":"additional","affiliation":[{"name":"Oxford UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R Andrew","family":"Moore","sequence":"additional","affiliation":[{"name":"Plymouth UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winfried","family":"H\u00e4user","sequence":"additional","affiliation":[{"name":"Department of Psychosomatic Medicine and Psychotherapy; Technische Universit\u00e4t M\u00fcnchen; M\u00fcnchen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,8,6]]},"reference":[{"key":"10.1002\/14651858.CD012708.pub2-BIB0001|cit1","unstructured":"A double-blind, placebo-controlled phase II study of Org 3770 (mirtazapine) in patients with fibromyalgia clinicaltrials.jp\/user\/showCteDetailE.jsp?japicId=JapicCTI-101176"},{"issue":"9","key":"10.1002\/14651858.CD012708.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1097\/j.pain.0000000000000622","article-title":"Efficacy of mirtazapine for the treatment of fibromyalgia without concomitant depression: a randomized, double-blind, placebo-controlled phase IIa study in Japan","volume":"157","author":"Miki","year":"2016","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1345\/aph.1R725","article-title":"Efficacy and safety of mirtazapine in fibromyalgia syndrome patients: a randomized placebo-controlled pilot study","volume":"47","author":"Yeephu","year":"2013","journal-title":"The Anals of Pharmacotherapy"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1007\/s00103-008-0648-9","article-title":"Pharmacoepidemiological research with large health databases","volume":"51","author":"Andersohn","year":"2008","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1527-3458.2001.tb00198.x","article-title":"A review of the pharmacological and clinical profile of mirtazapine","volume":"7","author":"Anttila","year":"2000","journal-title":"CNS Drug Review"},{"issue":"2","key":"10.1002\/14651858.CD012708.pub2-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/AJP.0b013e318159f94a","article-title":"Mirtazapine decreases the pain feeling in healthy participants","volume":"24","author":"Arnold","year":"2008","journal-title":"Clinical Journal of Pain"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/art.37842","article-title":"The fibromyalgia family study: a genome wide linkage scan study","volume":"65","author":"Arnold","year":"2013","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/art.33360","article-title":"Development of responder definitions for fibromyalgia clinical trials","volume":"64","author":"Arnold","year":"2012","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1471-2474-8-27","article-title":"An internet survey of 2,596 people with fibromyalgia","volume":"8","author":"Bennett","year":"2007","journal-title":"BMC Musculoskeletal Disorders"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/ejp.1121","article-title":"Efficacy, acceptability and safety of cognitive behavioural therapies in fibromyalgia syndrome - A systematic review and meta-analysis of randomized controlled trials","volume":"22","author":"Bernardy","year":"2018","journal-title":"European Journal of Pain"},{"issue":"6","key":"10.1002\/14651858.CD012708.pub2-BIB0011|cit11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012700","article-title":"Aerobic exercise training for adults with fibromyalgia","author":"Bidonde","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jpain.2015.06.004","article-title":"Bidirectional association between depression and fibromyalgia syndrome: a nationwide longitudinal study","volume":"16","author":"Chang","year":"2015","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.jpain.2010.01.267","article-title":"The association between incident self-reported fibromyalgia and nonpsychiatric factors: 25-years follow-up of the Adventist Health Study","volume":"11","author":"Choi","year":"2011","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1176\/appi.psy.50.3.299","article-title":"Repeated episodes of neutropenia triggered by mirtazapine","volume":"50","author":"Civalier","year":"2009","journal-title":"Psychosomatics"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00124743-199512000-00004","article-title":"The overlap between fibromyalgia and inflammatory rheumatic disease: when and why does it occur?","volume":"1","author":"Clauw","year":"1995","journal-title":"Journal of Clinical Rheumatology"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1001\/jama.2014.3266","article-title":"Fibromyalgia: a clinical review","volume":"311","author":"Clauw","year":"2014","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0017|cit17","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"issue":"2","key":"10.1002\/14651858.CD012708.pub2-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/rheumatology\/keu332","article-title":"Inadequate pain relief and large functional loss among patients with knee osteoarthritis: evidence from a prospective multinational longitudinal study of osteoarthritis real-world therapies","volume":"54","author":"Conaghan","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1002\/14651858.CD012708.pub2-BIB0019|cit19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012188.pub2","article-title":"Gabapentin for fibromyalgia pain in adults","author":"Cooper","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD012708.pub2-BIB0020|cit20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011790.pub2","article-title":"Pregabalin for pain in fibromyalgia in adults","author":"Derry","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0021|cit21","first-page":"215","article-title":"The effects of mirtazapine on sleep in patients with major depressive disorder","volume":"24","author":"Dolder","year":"2012","journal-title":"Annals of Clinical Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD012708.pub2-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11136-013-0443-4","article-title":"Don't middle your MIDs: regression to the mean shrinks estimates of minimally important differences","volume":"23","author":"Fayers","year":"2014","journal-title":"Quality of Life Research"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0024|cit24","unstructured":"Remeron\u00ae (mirtazapine) tablets www.fda.gov\/downloads\/Drugs\/DrugSafety\/ucm089021.pdf"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1155\/2013\/918216","article-title":"2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary","volume":"18","author":"Fitzcharles","year":"2013","journal-title":"Pain Research and Management"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0026|cit26","first-page":"2458-67","article-title":"Prognostic factors for the development of fibromyalgia in women with self reported musculoskeletal pain","volume":"26","author":"Forseth","year":"1999","journal-title":"Journal of Rheumatology"},{"issue":"2","key":"10.1002\/14651858.CD012708.pub2-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1185\/030079906X80486","article-title":"The effect of mirtazapine in patients with chronic pain and concomitant depression","volume":"22","author":"Freynhagen","year":"2006","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00296-010-1713-x","article-title":"Individuals with fibromyalgia and depression: findings from a nationally representative Canadian survey","volume":"32","author":"Fuller-Thomson","year":"2012","journal-title":"Rheumatology International"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00004850-200501000-00010","article-title":"Imputing response rates from means and standard deviations in meta-analyses","volume":"20","author":"Furukawa","year":"2005","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"e7888","DOI":"10.1136\/bmj.e7888","article-title":"The new BMJ policy on sharing data from drug and device trials","volume":"355","author":"Godlee","year":"2012","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jclinepi.2012.01.012","article-title":"GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0034|cit34","unstructured":"Higgins JP Altman DG Sterne JAC Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"2","key":"10.1002\/14651858.CD012708.pub2-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.pain.2009.09.017","article-title":"How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy?","volume":"149","author":"Hoffman","year":"2010","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/acr.20328","article-title":"Emotional, physical, and sexual abuse in fibromyalgia syndrome: a systematic review with meta-analysis","volume":"63","author":"H\u00e4user","year":"2011","journal-title":"Arthritis Care and Research"},{"issue":"2","key":"10.1002\/14651858.CD012708.pub2-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s00482-012-1161-5","article-title":"German fibromyalgia consumer reports. Benefits and harms of fibromyalgia syndrome therapies","volume":"26","author":"H\u00e4user","year":"2012","journal-title":"Schmerz"},{"issue":"1","key":"10.1002\/14651858.CD012708.pub2-BIB0038|cit38","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010292","article-title":"Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome","author":"H\u00e4user","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD012708.pub2-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.pain.2013.03.034","article-title":"Posttraumatic stress disorder in fibromyalgia syndrome: prevalence, temporal relationship between posttraumatic stress and fibromyalgia symptoms, and impact on clinical outcome","volume":"154","author":"H\u00e4user","year":"2013","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"15022","DOI":"10.1038\/nrdp.2015.22","article-title":"Fibromyalgia","volume":"2","author":"H\u00e4user","year":"2015","journal-title":"Nature Reviews Disease Primers"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s00482-014-1462-y","article-title":"Methodology of the development of the updated LONTS guidelines for long-term administration of opioids in noncancer pain","volume":"29","author":"H\u00e4user","year":"2015","journal-title":"Schmerz"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0042|cit42","unstructured":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Introductory Guide MedDRA Version 18.0 www.meddra.org\/sites\/default\/files\/guidance\/file\/intguide_18_0_english.pdf"},{"issue":"1","key":"10.1002\/14651858.CD012708.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"issue":"9219","key":"10.1002\/14651858.CD012708.pub2-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S0140-6736(99)11381-3","article-title":"SnaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression","volume":"355","author":"Kent","year":"2000","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD012708.pub2-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"224","DOI":"10.7326\/0003-4819-107-2-224","article-title":"Meta-analysis in clinical research","volume":"107","author":"L'Abb\u00e9","year":"1987","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012708.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s00482-010-0937-8","article-title":"Influence of depression on fibromyalgia: a systematic review","volume":"24","author":"Lange","year":"2010","journal-title":"Schmerz"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/2046-4053-2-81","article-title":"Assessing and presenting summaries of evidence in Cochrane Reviews","volume":"2","author":"Langendam","year":"2013","journal-title":"Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012708.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00296-010-1678-9","article-title":"Candidate gene studies of fibromyalgia: a systematic review and meta-analysis","volume":"32","author":"Lee","year":"2012","journal-title":"Rheumatology International"},{"issue":"6","key":"10.1002\/14651858.CD012708.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"949-54","DOI":"10.1136\/annrheumdis-2012-201506","article-title":"Incidence and predictors of secondary fibromyalgia in an early arthritis cohort","volume":"72","author":"Lee","year":"2013","journal-title":"Annals of Rheumatic Diseases"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.pain.2013.12.029","article-title":"Effectiveness of group acceptance and commitment therapy for fibromyalgia: a 6-month randomized controlled trial (EFFIGACT study)","volume":"155","author":"Luciano","year":"2014","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD012708.pub2-BIB0051|cit51","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007115.pub3","article-title":"Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia","author":"Lunn","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012708.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1136\/annrheumdis-2016-209724","article-title":"EULAR revised recommendations for the management of fibromyalgia","volume":"76","author":"Macfarlane","year":"2017","journal-title":"Annals of Rheumatic Diseases"},{"issue":"3","key":"10.1002\/14651858.CD012708.pub2-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/RHU.0000000000000089","article-title":"Sympathetic nervous system dysfunction in fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, and interstitial cystitis: a review of case-control studies","volume":"20","author":"Mart\u00ednez-Mart\u00ednez","year":"2014","journal-title":"Journal of Clinical Rheumatology"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0054|cit54","volume-title":"An Evidence-based Resource for Pain Relief","author":"McQuay","year":"1998"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00004850-199512004-00006","article-title":"Safety of mirtazapine: a review","volume":"10 Suppl 4","author":"Montgomery","year":"1995","journal-title":"International Clinical Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD012708.pub2-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0304-3959(98)00140-7","article-title":"Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects","volume":"78","author":"Moore","year":"1998","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0058|cit58","first-page":"15","volume-title":"Systematic Reviews in Pain Research: Methodology Refined","author":"Moore","year":"2008"},{"issue":"3","key":"10.1002\/14651858.CD012708.pub2-BIB0059|cit59","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007076.pub2","article-title":"Pregabalin for acute and chronic pain in adults","author":"Moore","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD012708.pub2-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.pain.2010.05.011","article-title":"\"Evidence\" in chronic pain - establishing best practice in the reporting of systematic reviews","volume":"150","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD012708.pub2-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.pain.2010.02.039","article-title":"Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD012708.pub2-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1136\/ard.2009.107805","article-title":"Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice","volume":"69","author":"Moore","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3","key":"10.1002\/14651858.CD012708.pub2-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.pain.2010.07.013","article-title":"Numbers-needed-to-treat analyses - do timing, dropouts, and outcome matter? Pooled analysis of two randomized, placebo-controlled chronic low back pain trials","volume":"151","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"5","key":"10.1002\/14651858.CD012708.pub2-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.pain.2010.11.030","article-title":"Minimum efficacy criteria for comparisons between treatments using individual patient meta-analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen\/paracetamol combinations after third molar extraction","volume":"152","author":"Moore","year":"2011","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD012708.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/EJA.0b013e328343c569","article-title":"Mean analgesic consumption is inappropriate for testing analgesic efficacy in post-operative pain: analysis and alternative suggestion","volume":"28","author":"Moore","year":"2011","journal-title":"European Journal of Anaesthesiology"},{"issue":"12","key":"10.1002\/14651858.CD012708.pub2-BIB0066|cit66","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008242.pub2","article-title":"Amitriptyline for neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012708.pub2-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.pain.2011.10.004","article-title":"Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses","volume":"153","author":"Moore","year":"2012","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD012708.pub2-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/anae.12148","article-title":"Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome","volume":"68","author":"Moore","year":"2013","journal-title":"Anaesthesia"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"f2690","DOI":"10.1136\/bmj.f2690","article-title":"Expect analgesic failure; pursue analgesic success","volume":"346","author":"Moore","year":"2013","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD012708.pub2-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/papr.12050","article-title":"The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain","volume":"14","author":"Moore","year":"2014","journal-title":"Pain Practice"},{"issue":"1","key":"10.1002\/14651858.CD012708.pub2-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/j.1532-2149.2013.00341.x","article-title":"Duloxetine use in chronic painful conditions - individual patient data responder analysis","volume":"18","author":"Moore","year":"2014","journal-title":"European Journal of Pain"},{"issue":"5","key":"10.1002\/14651858.CD012708.pub2-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/acr.20118","article-title":"Association between physical exercise, body mass index, and risk of fibromyalgia: longitudinal data from the Norwegian Nord-Tr\u00f8ndelag Health Study","volume":"62","author":"Mork","year":"2010","journal-title":"Arthritis Care and Research"},{"issue":"1","key":"10.1002\/14651858.CD012708.pub2-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/art.33346","article-title":"Sleep problems and risk of fibromyalgia: longitudinal data on an adult female population in Norway","volume":"64","author":"Mork","year":"2012","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jad.2017.08.002","article-title":"Can we recommend mirtazapine and bupropion for patients at risk for bleeding? A systematic review and meta-analysis","volume":"225","author":"Na","year":"2017","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0075|cit75","unstructured":"Study of Indoleamine 2,3-dioxygenase Activity, Serum Levels of Cytokines, BDNF, BH4 and Mirtazapine Efficacy in Fibromyalgia Syndrome https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00919295?term=NCT00919295&rank=1"},{"issue":"1","key":"10.1002\/14651858.CD012708.pub2-BIB0076|cit76","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1526-4637.2009.00685.x","article-title":"Patient-centered perspective on treatment outcomes in chronic pain","volume":"11","author":"O'Brien","year":"2010","journal-title":"Pain Medicine"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0077|cit77","unstructured":"PaPaS author and referee guidance papas.cochrane.org\/papas-documents"},{"issue":"10","key":"10.1002\/14651858.CD012708.pub2-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.sjpain.2016.07.002","article-title":"Osteoarthritis patients with pain improvement are highly likely to also have improved quality of life and functioning. A post hoc analysis of a clinical trial","volume":"13","author":"Peloso","year":"2016","journal-title":"Scandinavian Journal of Pain"},{"issue":"3","key":"10.1002\/14651858.CD012708.pub2-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s00482-017-0201-6","article-title":"General principles and coordination of care and patient education in fibromyalgia syndrome. Updated guideline 2017 and review of systematic reviews","volume":"31","author":"Petzke","year":"2017","journal-title":"Schmerz"},{"issue":"8","key":"10.1002\/14651858.CD012708.pub2-BIB0080|cit80","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s11916-013-0356-5","article-title":"Worldwide epidemiology of fibromyalgia","volume":"17","author":"Queiroz","year":"2013","journal-title":"Current Pain and Headache Reports"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0081|cit81","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3389\/fneur.2017.00307","article-title":"Adverse effects of antidepressants for chronic pain: a systematic review and meta-analysis","volume":"8","author":"Riediger","year":"2017","journal-title":"Frontiers in Neurology"},{"issue":"4","key":"10.1002\/14651858.CD012708.pub2-BIB0083|cit83","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1055\/s-2004-827172","article-title":"Open trial of mirtazapine in patients with fibromyalgia","volume":"37","author":"Samborski","year":"2004","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"10.1002\/14651858.CD012708.pub2-BIB0084|cit84","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00482-014-1451-1","article-title":"Opioids in chronic osteoarthritis pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration","volume":"29","author":"Schaefert","year":"2015","journal-title":"Schmerz"},{"issue":"2","key":"10.1002\/14651858.CD012708.pub2-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1365-2125.2008.03200","article-title":"Enriched enrolment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review","volume":"66","author":"Straube","year":"2008","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1471-2474-11-150","article-title":"Pregabalin in fibromyalgia - responder analysis from individual patient data","volume":"11","author":"Straube","year":"2010","journal-title":"BMC Musculoskeletal Disorders"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/1471-2474-12-125","article-title":"Interference with work in fibromyalgia: effect of treatment with pregabalin and relation to pain response","volume":"12","author":"Straube","year":"2011","journal-title":"BMC Musculoskeletal Disorders"},{"issue":"10","key":"10.1002\/14651858.CD012708.pub2-BIB0088|cit88","doi-asserted-by":"publisher","first-page":"e25491","DOI":"10.1371\/journal.pone.0025491","article-title":"The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis - a simulation study","volume":"6","author":"Thorlund","year":"2011","journal-title":"PLoS One"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4140\/TCP.n.2016.139","article-title":"Antidepressant-induced hyponatremia in older adults","volume":"31","author":"Viramontes","year":"2016","journal-title":"The Consultant Pharmacist"},{"issue":"9859","key":"10.1002\/14651858.CD012708.pub2-BIB0090|cit90","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos","year":"2012","journal-title":"Lancet"},{"issue":"12","key":"10.1002\/14651858.CD012708.pub2-BIB0091|cit91","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006528","article-title":"Mirtazapine versus other antidepressive agents for depression","author":"Watanabe","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0092|cit92","unstructured":"Remerone anyone? forums.webmd.com\/3\/fibromyalgia-exchange\/forum\/3685"},{"issue":"11","key":"10.1002\/14651858.CD012708.pub2-BIB0093|cit93","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010567.pub2","article-title":"Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews","author":"Wiffen","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012708.pub2-BIB0094|cit94","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis and Rheumatism"},{"issue":"5","key":"10.1002\/14651858.CD012708.pub2-BIB0095|cit95","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care and Research"},{"issue":"6","key":"10.1002\/14651858.CD012708.pub2-BIB0096|cit96","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3899\/jrheum.100594","article-title":"Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia","volume":"38","author":"Wolfe","year":"2011","journal-title":"Journal of Rheumatology"},{"issue":"2","key":"10.1002\/14651858.CD012708.pub2-BIB0097|cit97","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.pain.2010.09.027","article-title":"The development of fibromyalgia - I: Examination of rates and predictors in patients with rheumatoid arthritis (RA)","volume":"152","author":"Wolfe","year":"2011","journal-title":"Pain"},{"issue":"5","key":"10.1002\/14651858.CD012708.pub2-BIB0098|cit98","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/acr.21931","article-title":"Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population","volume":"645","author":"Wolfe","year":"2013","journal-title":"Arthritis Care and Research"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/j.1532-2149.2012.00234.x","article-title":"Longitudinal patterns of analgesic and central acting drug use and associated effectiveness in fibromyalgia","volume":"17","author":"Wolfe","year":"2013","journal-title":"European Journal Pain"},{"issue":"7","key":"10.1002\/14651858.CD012708.pub2-BIB0100|cit100","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/acr.22207","article-title":"What is fibromyalgia, how is it diagnosed and what does it really mean?","volume":"66","author":"Wolfe","year":"2014","journal-title":"Arthritis Care and Research"},{"issue":"3","key":"10.1002\/14651858.CD012708.pub2-BIB0101|cit101","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","article-title":"2016 Revisions to the 2010\/2011 fibromyalgia diagnostic criteria","volume":"46","author":"Wolfe","year":"2016","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD012708.pub2-BIB0102|cit102","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/1471-2474-12-245","article-title":"Systematic review with meta-analysis: cytokines in fibromyalgia syndrome","volume":"12","author":"\u00dcceyler","year":"2011","journal-title":"BMC Musculoskeletal Disorders"},{"issue":"3","key":"10.1002\/14651858.CD012708.pub2-BIB0103|cit103","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00482-017-0202-5","article-title":"Etiology and pathophysiology of fibromyalgia syndrome: Updated guideline 2017, overview of systematic reviews and review of studies on small fiber pathology in subgroups of fibromyalgia syndrome","volume":"31","author":"\u00dc\u00e7eyler","year":"2017","journal-title":"Schmerz"},{"issue":"6","key":"10.1002\/14651858.CD012708.pub2-BIB0104|cit104","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012708","article-title":"Mirtazapine for fibromyalgia in adults","author":"Welsch","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD012708.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T23:09:51Z","timestamp":1628550591000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD012708.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,8,6]]},"references-count":104,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012708.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,6]]}}}